Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)

Completed · Phase 3

Conditions studied: Respiratory Failure

In brief

The purpose of this study is to determine if the use of a silver-coated endotracheal tube (ETT) can reduce the incidence and/or delay the time of onset of VAP when compared to a non silver-coated ETT in patients who have been mechanically ventilated for \>= 24 hours.

Key facts

Study ID

NCT00148642

Run by

C. R. Bard

People needed

2003

Starts

2002-11-01

Expected to finish

2006-03-01

Last updated by the study team

2017-01-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age > 18 years
• expected to be intubated for at least 24 hours
• able to sign Informed Consent

You may not qualify if…

• symptoms of bronchiectasis
• severe hemoptysis
• history of cystic fibrosis
• intubated > 12 hours within previous 30 days
• pregnancy
• participating in a competing trial

Where it is running

• University of California, San Diego — San Diego, California, United States
• West Suburban Hospital — Oak Park, Illinois, United States
• Mayo Clinic & Foundation — Rochester, Minnesota, United States
• St. John's Mercy Medical Center — St Louis, Missouri, United States
• Audie Murphy VA Medical Center & University Hospital — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.